跳转至内容
Merck
所有图片(1)

Key Documents

935794

Sigma-Aldrich

Multiphoton lithography bioink kit

gelatin-based hydrogel bioink

别名:

HYDROBIO INX X100

登录查看公司和协议定价


About This Item

分類程式碼代碼:
12352201
NACRES:
NB.02

品質等級

形狀

gel form

顏色

red

膨潤

swells to 50-250 (Post processing total volume increase (%))

凝膠強度

(Storage modulus 4-26 kPa)

正在寻找类似产品? 访问 产品对比指南

一般說明

This gelatin-based bioink kit for multiphoton lithography (MPL) combines the biological benefits of conventional gelatin-based materials with two-photon polymerization processability. It is based on gelatin type B derived from natural collagen which is modified with photo-crosslinkable functional groups enabling efficient multiphoton processing at 780 nm in the presence of the supplied crosslinker. The gelatin-based bioink can be processed at fast speeds, due to the high reactivity and fast curing, resulting in high cell viability. The bioink is also biodegradable and allows cells to remodel the envrionment and substitute the hydrogel with newly formed extracellular matrix over time. This ready-to-use kit contains a concentrated resin, dilution buffer, and crosslinker for 10 prints.

應用

A wide range of biological applications including:
  • 3D bioprinting
  • Tissue engineering
  • High resolution printing of complex geometries

特點和優勢

  • Biocompatibility - Supports cell adhesion and proliferation
  • Reproducibility - Production under strict quality control
  • Biodegradability - Enables cellular remodelling of the printed matrix
  • Easy handling - Delivered in a ready-to-use kit containing a concentrated stock solution, dilution buffer, and crosslinker for 10 prints that can be printed in 10 min
  • Biolgoically relevant - includes the benefits of collagen derived GelMA

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Acute Tox. 4 Oral - Aquatic Chronic 3

儲存類別代碼

10 - Combustible liquids

水污染物質分類(WGK)

WGK 3


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

抱歉,我们目前尚未线上提供该产品的COA。

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Multiphoton Lithography as a Promising Tool for Biomedical Applications
Greant C, et al.
Advanced Functional Materials , 33, 2212641-2212641 (2023)
Olivier Guillaume et al.
Acta biomaterialia, 165, 72-85 (2022-03-16)
Since its inception, tissue engineering and regenerative medicine (TERM) has been relying on either scaffold-based or scaffold-free strategies. Recent reports outlined the possibility of a synergistic, convergence approach, referred to as the third TERM strategy, which could alleviate bottlenecks of

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门